Johnson & Johnson (J&J) has formally appealed a federal judge’s ruling that drugmakers cannot unilaterally implement a 340B rebate model—a [...] …
Category: Pharma Industry
Federal Judge Denies AbbVie’s Bid to Block Tennessee 340B Contract Pharmacy Access Law’s Enforcement
A Nashville federal district judge on Monday denied AbbVie’s request to block enforcement of Tennessee’s new 340B contract pharmacy protections, [...] …
The Health Resources and Services Administration (HRSA) recently reinstated eight Sagebrush sites into the 340B program—just one day before a [...] …
Two major drugmakers recently announced additional states that will no longer be subject to their 340B contract pharmacy restrictions following [...] …
The head of an influential drug industry trade group and a former Trump administration official recently called for federal 340B [...] …
A federal district judge today upheld the Department of Health and Human Services’ (HHS) authority to preapprove 340B rebate models, [...] …
In their second emergency motion this month, a group of drugmakers is urging a federal appeals court to reject a [...] …
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. this week defended President Donald Trump’s Fiscal Year 2026 proposed [...] …
Drugmakers Amgen, GSK, Merck and Sobi recently announced they are exempting more states from their 340B contract pharmacy restrictions amid [...] …
Maine recently became the 20th state to enact a 340B contract pharmacy access law as part of a sweeping budget [...] …